Sands Capital Ventures, LLC Long-Term Concentrated

CIK: 0001846444 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Jan 21, 2022

Total Value ($000): $674,708 (100.0% shares, 0.0% debt)

Holdings (16)

PATH UIPATH INC 24.4%

Value ($000) $164,402 Shares 3,811,779 Est. Cost $60.53 Unrealized -18.5%

DASH DOORDASH INC 13.3%

Value ($000) $89,557 Shares 601,454 Est. Cost $191.28 Unrealized -1.0%

NU NU HOLDINGS LTD. 12.7%

Value ($000) $85,704 Shares 9,136,835 Est. Cost $9.82 Unrealized 0.0%

— DICE THERAPEUTICS, INC. 11.8%

Value ($000) $79,700 Shares 3,148,970 Est. Cost $32.75 Unrealized —

— SAMSARA, INC. 11.3%

Value ($000) $76,242 Shares 2,712,256 Est. Cost $28.11 Unrealized —

SNOW SNOWFLAKE INC 10.8%

Value ($000) $72,703 Shares 214,621 Est. Cost $284.41 Unrealized +22.5%

— KARUNA THERAPEUTICS, INC. 5.2%

Value ($000) $35,094 Shares 267,895 Est. Cost $122.33 Unrealized —

ABOS ACUMEN PHARMACEUTICALS, INC 3.4%

Value ($000) $23,099 Shares 3,417,075 Est. Cost $16.64 Unrealized -33.9%

IOT SAMSARA, INC. 1.4%

Value ($000) $9,164 Shares 326,000 Est. Cost $26.05 Unrealized 0.0%

TSHA TAYSHA GENE THERAPIES INC 1.3%

Value ($000) $8,445 Shares 724,873 Est. Cost $19.01 Unrealized -20.7%

MASS 908 DEVICES INC 1.3%

Value ($000) $8,445 Shares 326,427 Est. Cost $33.97 Unrealized -13.4%

CADL CANDEL THERAPEUTICS, INC 0.9%

Value ($000) $6,348 Shares 811,737 Est. Cost $8.29 Unrealized +17.1%

RGEN REPLIGEN CORP. 0.9%

Value ($000) $5,971 Shares 22,544 Est. Cost $256.54 Unrealized +5.0%

TARS TARSUS PHARMACEUTICALS INC 0.9%

Value ($000) $5,850 Shares 260,000 Est. Cost $24.75 Unrealized +5.0%

— SPRUCE BIOSCIENCES INC 0.5%

Value ($000) $3,510 Shares 787,007 Est. Cost $6.01 Unrealized —

ABSI ABSCI CORP. 0.1%

Value ($000) $474 Shares 57,804 Est. Cost $19.41 Unrealized -41.3%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PATH	UIPATH INC	3,811,779	$164,402	24.4%	$60.53	-18.5%	COM CL A	90364P105
DASH	DOORDASH INC	601,454	$89,557	13.3%	$191.28	-1.0%	COM CL A	25809K105
NU	NU HOLDINGS LTD.	9,136,835	$85,704	12.7%	$9.82	0.0%	COM CL A	G6683N103
—	DICE THERAPEUTICS, INC.	3,148,970	$79,700	11.8%	$32.75	—	COM	23345J104
—	SAMSARA, INC.	2,712,256	$76,242	11.3%	$28.11	—	COM CL B	FDS1Q2O30
SNOW	SNOWFLAKE INC	214,621	$72,703	10.8%	$284.41	+22.5%	COM CL A	833445109
—	KARUNA THERAPEUTICS, INC.	267,895	$35,094	5.2%	$122.33	—	COM	48576A100
ABOS	ACUMEN PHARMACEUTICALS, INC	3,417,075	$23,099	3.4%	$16.64	-33.9%	COM	00509G209
IOT	SAMSARA, INC.	326,000	$9,164	1.4%	$26.05	0.0%	COM CL A	79589L106
TSHA	TAYSHA GENE THERAPIES INC	724,873	$8,445	1.3%	$19.01	-20.7%	COM	877619106
MASS	908 DEVICES INC	326,427	$8,445	1.3%	$33.97	-13.4%	COM	65443P102
CADL	CANDEL THERAPEUTICS, INC	811,737	$6,348	0.9%	$8.29	+17.1%	COM	137404109
RGEN	REPLIGEN CORP.	22,544	$5,971	0.9%	$256.54	+5.0%	COM	759916109
TARS	TARSUS PHARMACEUTICALS INC	260,000	$5,850	0.9%	$24.75	+5.0%	COM	87650L103
—	SPRUCE BIOSCIENCES INC	787,007	$3,510	0.5%	$6.01	—	COM	85209E109
ABSI	ABSCI CORP.	57,804	$474	0.1%	$19.41	-41.3%	COM	00091E109